# FDA Inspection 1225745 - Lucina BioSciences, LLC - December 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/lucina-biosciences-llc/c8a252bb-d3a0-4c13-9b04-4f6c06d8a9cd
Source feed: FDA_Inspections

> FDA Inspection 1225745 for Lucina BioSciences, LLC on December 18, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225745
- Company Name: Lucina BioSciences, LLC
- Inspection Date: 2023-12-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1148566 - 2021-08-10](https://www.keypedia.com/records/fda_inspections/lucina-biosciences-llc/d5d2d9d1-c723-4570-ad58-1050d4c1d284)
- [FDA Inspection 1148566 - 2021-08-10](https://www.keypedia.com/records/fda_inspections/lucina-biosciences-llc/1445314d-b98d-4e71-a96a-fd8b5a9e9140)
- [FDA Inspection 1148566 - 2021-08-10](https://www.keypedia.com/records/fda_inspections/lucina-biosciences-llc/fc09395c-8d33-44fd-ae44-992658ea67f5)

Company: https://www.keypedia.com/companies/lucina-biosciences-llc/fc4717fd-218b-44ce-a6e4-c87aace6ba87

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d